awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30902172-1A2014FD-6B73-489A-988F-7285A0C434FE
Q30902172-1A2014FD-6B73-489A-988F-7285A0C434FE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30902172-1A2014FD-6B73-489A-988F-7285A0C434FE
Current, new and future biological agents on the horizon for the treatment of inflammatory bowel diseases.
P2860
Q30902172-1A2014FD-6B73-489A-988F-7285A0C434FE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30902172-1A2014FD-6B73-489A-988F-7285A0C434FE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
47a57afc0a89987d7619a65415c6e8517d356ab8
P2860
Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.